Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000085

EVP, Global Research and CSO sold 3,002 shares at $421.77 ($1,266,154)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ALTSHULER DAVID · EVP, Global Research and CSO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-21 Sale : show line 1 in the form 10b5-1 −3,002 $421.77 $1,266,154 34,022 D
Open-market sales · 3,002 sh · avg $421.77 · $1,266,154
Loading xslF345X05/wk-form4_1708722602.xml…